High-dose intravenous vitamin C reduce C-reactive protein levels, fluid retention, and APACHE II scores in patients with moderately severe acute pancreatitis: a prospective, randomized, double-blinded, placebo-controlled study
Primary result · 28-day mortalityResult — go to the resultUnadjusted odds ratio 0.70 95% CI 0.15–3.21- terminated prematurely
Authors' conclusion
HDIVC did not significantly reduce 28-day mortality in MSAP and SAP patients.
Study context
- Population
- Adults with predicted moderately severe (moderately severe acute pancreatitis (MSAP)) or severe acute pancreatitis (SAP) within 72 h of symptom onset155 MSAP, 57 SAP
- Participants
- 212 adults
- Comparison
- High-dose IV vitamin C vs matched placebo for 7 days
- High-dose intravenous vitamin C (HDIVC)n = 109
- Controln = 103reference
- Primary endpoint
- 28-day mortality
- Follow-up
- 28 days
Methodological detailsdouble-blinded, placebo-controlled, Enrolled September 2019 to June 2023
- Double-blinded
- Placebo-controlled
- Enrolled September 2019 to June 2023
Primary result
As reported in the abstract
Unadjusted odds ratio
0.70
95% CI 0.15–3.21
P = 0.647
Events by treatment group
HDIVC
3 of 109
3 of 109
Control
4 of 103
4 of 103
HDIVC vs Control
unadjusted OR 0.70 (95% CI 0.15–3.21); P = 0.647
Further findings
Fluid retention volume, MSAP (subgroup) · Day0-Day1
P = 0.04
Fluid retention volume, MSAP (subgroup) · Day0-Day2
P = 0.02
Fluid retention volume, MSAP (subgroup) · Day0-Day3
P = 0.04
| Outcome | HDIVC | Control | P value |
|---|---|---|---|
| CRP reduction, MSAP (subgroup) · Day0 to Day3Median, mg/L | 72 | 46 | P = 0.003 |
| CRP reduction, MSAP (subgroup) · Day0 to Day7Median, mg/L | 168 | 121 | P = 0.013 |
| APACHE II score reduction, MSAP (subgroup) · Day0 to Day7Median | 3 | 2 | P = 0.01 |
SAP (subgroup)
- No significant difference among patients with SAP
Original publication
High-dose intravenous vitamin C reduce C-reactive protein levels, fluid retention, and APACHE II scores in patients with moderately severe acute pancreatitis: a prospective, randomized, double-blinded, placebo-controlled study. Ann Intensive Care. Published 17 March 2025. doi:10. 1186/ s13613-025-01437-z
Composed by AI from the published abstract and checked against it. How Briefs are made →